stavudine has been researched along with Hypertriglyceridemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fekade, D; Feleke, Y; Mezegebu, Y | 1 |
| Anunnatsiri, S; Boonyaprawit, P; Chetchotisakd, P; Mootsikapun, P | 1 |
| Aurpibul, L; Lee, B; Mangklabruks, A; Puthanakit, T; Sirisanthana, T; Sirisanthana, V | 1 |
| Gurgo, AM; Iulianella, R; Luciani, C; Lucifero, A; Massino Ferri, F; Rocchi, M; Staropoli, P | 1 |
| Basdevant, A; Capeau, J; Chêne, G; Leport, C; Perronne, C; Raffi, F; Ragnaud, JM; Rozenbaum, W; Savès, M | 1 |
1 trial(s) available for stavudine and Hypertriglyceridemia
| Article | Year |
|---|---|
Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.
Topics: Administration, Oral; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hypercholesterolemia; Hyperglycemia; Hypertriglyceridemia; Indinavir; Lamivudine; Male; Ritonavir; RNA, Viral; Stavudine; Thailand; Treatment Outcome; Viral Load; Withholding Treatment | 2005 |
4 other study(ies) available for stavudine and Hypertriglyceridemia
| Article | Year |
|---|---|
Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
Topics: Adult; Aged, 80 and over; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Cross-Sectional Studies; Ethiopia; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypercholesterolemia; Hyperglycemia; Hypertriglyceridemia; Interviews as Topic; Male; Metabolic Diseases; Middle Aged; Prevalence; Risk Factors; Stavudine; Surveys and Questionnaires; Zidovudine | 2012 |
Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
Topics: Adolescent; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Child; Child, Preschool; Cyclopropanes; Female; HIV Infections; HIV-1; Humans; Hypercholesterolemia; Hyperglycemia; Hypertriglyceridemia; Lamivudine; Lipodystrophy; Male; Nevirapine; Prevalence; Reverse Transcriptase Inhibitors; Stavudine; Thailand | 2007 |
[Acute myocardial infarct in HIV-positive patients in treatment with protease inhibitors].
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hypertriglyceridemia; Male; Myocardial Infarction; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine | 2001 |
Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy.
Topics: Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cohort Studies; HIV Infections; Humans; Hypertriglyceridemia; Lipodystrophy; Ritonavir; Stavudine | 2002 |